In some cases, t-SNE analysis could be used to further refine survival prediction among patients who had been previously well-stratified by such classical criteria as hormone receptor status in the case of breast cancer or by clinical staging in bladder cancer and head and neck cancer. The gene discussed is NR4A1; the disease is breast cancer.